Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Carbamazepine For Hemi Facial Spasm

G. E. Alexander, H. Moses
Published 1982 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Carbamazepine in daily doses of 600 to 1200 mg controlled hemi facial spasm in three patients. In other reports, carbamazepine was effective in over half of the patients. Controlled trials are needed to established whether Carbamazepine is as effective as the surgical therapies currently in vogue.
This paper references
10.1093/BRAIN/68.1.23
THE ARTERIAL RELATIONS OF THE INTERNAL AUDITORY MEATUS
S. Sunderland (1945)
Primary hemifacial spasm and its treatment with carbamazepine
P. Martinelli (1976)
Hemifacial spasm: a clinical pathophy- siological study
R. Wartenburg (1952)
10.1097/00006534-198706000-00032
The facial nerve.
M. May (1983)
Hemifacial spasm: review of 106 cases
G. Ehni (1945)
Der Spasmus f a c i a l i s kl inisher Bericht iiber 25 Pa t ien ten
H Maxion (1971)
Traitement de I’hemispasme facial essential par le tegretol
M Weber (1972)
Die Therapie des Hemispasmus facialis mit Te- gretol
J. Pechan (1972)
10.1001/ARCHOTOL.1972.00770080550013
Facial nerve block in the treatment of facial spasm.
B. Wakasugi (1972)
10.1097/00005053-188702000-00011
A Manual of Diseases of the Nervous System
W. Gowers (1887)
Isch-Treussard C. Essai de traitement de l’hemispasme facial primitif par le tegretol (Geigi)
MM Jesel (1964)
10.1001/ARCHNEUR.1974.00490370089016
Hemifacial spasm in childhood treated with carbamazepine.
B. Shaywitz (1974)
10.1136/jnnp.11.4.243
NEUROVASCULAR RELATIONS AND ANOMALIES AT THE BASE OF THE BRAIN
S. Sunderland (1948)
10.3171/JNS.1962.19.3.0240
Hemifacial Spasm—a Reversible Pathophysiologic State*
W. J. Gardner (1962)
10.1017/S0022215100082451
The facial tics.
M. S. Harrison (1976)
10.3171/JNS.1977.47.3.0321
Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients.
P. Jannetta (1977)
10.1016/0022-510X(69)90043-4
A hereditary neurological disease with facial spasm.
P. O. Lundberg (1969)
Idiopathic hemifacial spasm: pathogenesis and surgical treatment
JL Pulec (1972)
10.3171/JNS.1969.31.1.0106
Partial extracranial section of seventh nerve for hemi-facial spasm.
W. Scoville (1969)
10.1002/ANA.410040202
Hemifacial spasm and the facial nucleus
J. Ferguson (1978)
Essai de traitement de l'hemispasme facial primitif par le tegretol (Geigi)
M M Jesel (1964)
10.1136/jnnp.41.9.829
Hemifacial spasm: treatment by posterior fossa surgery.
G. Fabinyi (1978)
Intracranial crushing of the facial nerve for hemifacial spasm
F H Bragdon (1960)
10.1001/ARCHNEUR.1978.00500320001001
Hemifacial spasm. A vascular cause.
J. Maroon (1978)
Intracranial crushing of the facial nerve for hemifacial spasm. Presented a t the 46th Congress of the American College of Surgeons
FH Bragdon (1960)
Nervus inter- medius
AL Rhoton (1968)



This paper is referenced by
10.1097/WNF.0b013e31819a68dc
Idiopathic Hemifacial Spasm Responsive to Zonisamide: A Case Report
A. Siniscalchi (2009)
10.1016/B978-0-7216-9491-7.50053-3
Chapter 50 – Diseases of the Seventh Cranial Nerve
C. M. Klein (2005)
10.3109/00207458708987410
Baclofen in hemifacial spasm.
R. Sandyk (1987)
10.1016/j.survophthal.2010.03.008
Review and update of involuntary facial movement disorders presenting in the ophthalmological setting.
A. Ross (2011)
10.1038/s41598-017-10798-w
Typewriter tinnitus revisited: The typical symptoms and the initial response to carbamazepine are the most reliable diagnostic clues
W. Sunwoo (2017)
10.1016/j.pediatrneurol.2016.01.007
Hemifacial Spasm in a Child Treated With Microvascular Decompression of the Facial Nerve.
P. C. Vásquez (2016)
10.1016/j.jocn.2015.02.032
Botulinum toxin injections for the treatment of hemifacial spasm over 16years
M. Sorgun (2015)
10.1016/B978-343723390-6.50056-5
Kapitel 51 – Hirnnervenerkrankungen
Andrea Jaspert-Grehl (2005)
10.1177/15910199970030S204
Interventional Neuroradiology in Hemifacial Spasm
K. Yamashita (1997)
Hemifacial spasm in Singapore: clinical characteristics and patients ' perceptions.
W. L. Au (2004)
10.1001/JAMA.1982.03330230060037
Blinking and blepharospasm. Mechanism, diagnosis, and management.
J. Jankovic (1982)
10.1097/WNF.0b013e3180479755
Topiramate as Treatment for Hemifacial Spasm
H. Alonso-Navarro (2007)
10.1007/978-1-4939-0261-3_3
Clinical Use of Botulinum Neurotoxin: Neuromuscular Disorders
A. Guidubaldi (2014)
10.5631/JIBIRINSUPPL.148.2
Neurovascular Compression Syndrome with Intermittent Hemifacial Spasm and Simultaneous Tinnitus
E. Yanagi (2016)
10.1093/QJMED/95.8.493
Hemifacial spasm and involuntary facial movements.
N. Tan (2002)
10.1007/BF01402110
The cranial nerve vascular compression syndrome: II. A review of pathophysiology
A. R. Møller (2005)
10.1007/s11910-014-0512-2
An Update and Review of the Treatment of Myoclonus
K. Mills (2014)
10.3171/JNS.1984.61.3.0569
On the origin of synkinesis in hemifacial spasm: results of intracranial recordings.
A. Møller (1984)
10.1016/0967-5868(95)90005-5
Treatment of hemifacial spasm with botulinum toxin
IT Lorentz (1995)
10.1007/978-981-15-5417-9_14
Medical Treatment of Hemifacial Spasm and Other Involuntary Facial Movement Disorders
Wooyoung Jang (2020)
10.5631/JIBIRINSUPPL1986.1993.SUPPLEMENT66_43
Hemifacial Spasm; EMG-Histogram Evaluation
H. Saito (1993)
Descompresión microvascular para el espasmo hemifacial. Experiencia de 10 años
R. Revuelta-Gutiérrez (2003)
10.1016/B978-1-4160-4928-9.00010-X
Chapter 10 – Botulinum Neurotoxin in Tremors, Tics, Hemifacial Spasm, Spasmodic Dysphonia, and Stuttering
A. Bentivoglio (2009)
10.1007/BF02340723
Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group
A. Berardelli (2006)
10.1007/978-3-642-85090-5_22
Pathophysiology of hemifacial spasm.
A. Møller (1994)
Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
A. Suputtitada (2004)
10.1016/j.neurol.2014.07.016
Facial myokymia and autonomic synkinesis responsive to carbamazepine.
J. Lavrador (2015)
10.1136/jnnp.49.7.827
Botulinum toxin treatment of hemifacial spasm.
J. Elston (1986)
10.1007/s11940-017-0475-0
Treatment of Blepharospasm/Hemifacial Spasm
Kemar E Green (2017)
10.1111/j.1468-1331.2006.01670.x
Microvascular decompression for hemifacial spasm: postoperative neurologic follow‐up and evaluation of life quality
K. Heuser (2007)
10.1001/ARCHOTOL.1988.01860240057024
Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)
A. W. Biglan (1988)
10.1111/j.1600-0447.1984.tb07156.x
Profile of clinical efficacy and side effects of carbamazepine in psychiatric illness
R. Post (1984)
See more
Semantic Scholar Logo Some data provided by SemanticScholar